Literature DB >> 21059865

Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women.

Flavia Tosi1, Carlo Negri, Elisabetta Brun, Roberto Castello, Giovanni Faccini, Enzo Bonora, Michele Muggeo, Vincenzo Toscano, Paolo Moghetti.   

Abstract

OBJECTIVE: In hyperandrogenic women, hyperinsulinaemia amplifies 17 α-hydroxycorticosteroid intermediate response to ACTH, without alterations in serum cortisol or androgen response to stimulation. The aim of the study is to assess whether acute hyperinsulinaemia determines absolute changes in either basal or ACTH-stimulated adrenal steroidogenesis in these subjects. DESIGN AND METHODS: Twelve young hyperandrogenic women were submitted in two separate days to an 8 h hyperinsulinaemic (80  mU/m² × min) euglycaemic clamp, and to an 8 h saline infusion. In the second half of both the protocols, a 4 h ACTH infusion (62.5  μg/h) was carried out. Serum cortisol, progesterone, 17 α-hydroxyprogesterone (17-OHP), 17 α-hydroxypregnenolone (17-OHPREG), DHEA and androstenedione were measured at basal level and during the protocols. Absolute adrenal hormone secretion was quantified by measuring C19 and C21 steroid metabolites in urine collected after the first 4 h of insulin or saline infusion, and subsequently after 4 h of concurrent ACTH infusion.
RESULTS: During insulin infusion, ACTH-stimulated 17-OHPREG and 17-OHP were significantly higher than during saline infusion. No significant differences in cortisol and androgens response to ACTH were found between the protocols. Nevertheless, urinary excretion of ACTH-stimulated C19 and C21 steroid metabolites was significantly higher during hyperinsulinaemia than at basal insulin levels (both P < 0.005). Changes in steroid metabolites molar ratios suggested stimulation by insulin of 5 α-reductase activity.
CONCLUSIONS: These in vivo data support the hypothesis that insulin acutely enhances ACTH effects on both the androgen and glucocorticoid pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059865     DOI: 10.1530/EJE-10-0782

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  14 in total

1.  How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

Authors:  P Moghetti; E Carmina; V De Leo; A Lanzone; F Orio; R Pasquali; V Toscano
Journal:  J Endocrinol Invest       Date:  2015-04-03       Impact factor: 4.256

Review 2.  Insulin resistance and PCOS: chicken or egg?

Authors:  P Moghetti; F Tosi
Journal:  J Endocrinol Invest       Date:  2020-07-09       Impact factor: 4.256

Review 3.  Application of proteomics to the study of polycystic ovary syndrome.

Authors:  M Insenser; H F Escobar-Morreale
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 4.256

Review 4.  Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.

Authors:  Bhaskar Venkata Kameswara Subrahmanya Lakkakula; Maheswari Thangavelu; Usha Rani Godla
Journal:  J Assist Reprod Genet       Date:  2013-06-22       Impact factor: 3.412

Review 5.  Childhood obesity and its impact on the development of adolescent PCOS.

Authors:  Amy D Anderson; Christine M Burt Solorzano; Christopher R McCartney
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

Review 6.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 7.  Management of adolescents with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Dix P Poppas
Journal:  Lancet Diabetes Endocrinol       Date:  2013-11-15       Impact factor: 32.069

Review 8.  The role of miRNAs in polycystic ovary syndrome with insulin resistance.

Authors:  Yingliu Luo; Chenchen Cui; Xiao Han; Qian Wang; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

9.  Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Mohammad Alizadeh; Majid Karandish; Mohammad Asghari Jafarabadi; Lida Heidari; Roshan Nikbakht; Hossein Babaahmadi Rezaei; Reihaneh Mousavi
Journal:  Nutr Metab (Lond)       Date:  2021-06-06       Impact factor: 4.169

10.  The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.

Authors:  Pomme I H G Simons; Olivier Valkenburg; Judith A P Bons; Coen D A Stehouwer; Martijn C G J Brouwers
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.